Prof. Dr. Doğan Uncu

• Stomach Neoplasms 18 publications
  Source: OpenAlex / PubMed MeSHView publications
• Adenocarcinoma 15 publications
• Colorectal Neoplasms 15 publications
• Lung Neoplasms 14 publications
• Breast Neoplasms 13 publications
• Carcinoma, Non-Small-Cell Lung 7 publications
• Liver Neoplasms 7 publications
• Ovarian Neoplasms 7 publications
• Pancreatic Neoplasms 6 publications
• Bone Neoplasms 5 publications
• Colonic Neoplasms 4 publications
• Peritoneal Neoplasms 4 publications
• Lymphoma, Large B-Cell, Diffuse 4 publications
• Urinary Bladder Neoplasms 4 publications
• Rectal Neoplasms 4 publications
• Neoplasms 4 publications
• Brain Neoplasms 4 publications
• Neoplasms, Multiple Primary 3 publications
• Carcinoma, Hepatocellular 3 publications
• Granulosa Cell Tumor 3 publications
• Sarcoma, Ewing 3 publications
• Adenocarcinoma, Mucinous 3 publications
• Neutropenia 3 publications
• Endometrial Neoplasms 2 publications
• Gastrointestinal Neoplasms 2 publications
• Carcinoma, Squamous Cell 2 publications
• Duodenal Neoplasms 2 publications
• Nausea 2 publications
• Hypercalcemia 2 publications
• Carcinoma, Ductal, Breast 2 publications
• Carcinoma, Lobular 2 publications
• Common Bile Duct Neoplasms 2 publications

Medical areas of interest stated by the doctor on the institution profile. Source: medicalpark.com.tr.

Experience

• 1998to 2003: Ankara Numune Training and Research Hospital, Internal Medicine Residentmedicalpark.com.tr
• 2003to 2006: Ankara Numune Training and Research Hospital, Medical Oncology Subspecialty Fellowmedicalpark.com.tr
• 2007to 2008: Gülhane Military Medical Academy, Division of Medical Oncology, military service (medical officer, Second Lieutenant)medicalpark.com.tr
• 2008to 2010: Ankara Numune Training and Research Hospital, Medical Oncology Specialistmedicalpark.com.tr
• 2010to 2018: Ankara Numune Training and Research Hospital, Educational Supervisor (Eğitim Görevlisi) in Medical Oncologymedicalpark.com.tr
• 2018to 2019: University of Health Sciences, Ankara Numune SUAM, Medical Oncology, Education and Administrative Leadmedicalpark.com.tr
• 2019to 2025: University of Health Sciences, Ankara Bilkent City Hospital, Medical Oncology, Education and Administrative Leadmedicalpark.com.tr

Education

• 1992to 1998: Hacettepe University Faculty of Medicine, Medical degreemedicalpark.com.tr
• 1998to 2003: Ankara Numune Training and Research Hospital, Specialty training in Internal Medicinemedicalpark.com.tr
• 2003to 2006: Ankara Numune Training and Research Hospital, Subspecialty training (fellowship) in Medical Oncologymedicalpark.com.tr
• 2012to 2018: Ankara Numune Training and Research Hospital, Associate Professorship in Medical Oncologymedicalpark.com.tr
• Education2018: University of Health Sciences, Ankara Numune SUAM, Professorship in Medical Oncologymedicalpark.com.tr

• SpecialtyMedical Oncologymedicalpark.com.trFrom source
• Department name at the sourceMedikal Onkoloji (Tıbbi Onkoloji)medicalpark.com.trFrom source
• Institutionİstinye Üniversitesi Medical Park Gaziosmanpaşa, İstinye Üniversitesi Gaziosmanpaşa Hastanesimedicalpark.com.trFrom source
• Area of workStomach NeoplasmsExtracted from 18 publications · Model version —From source
• Publications218 publicationsOpenAlex, ORCIDFrom source
• ORCID0000-0002-0929-3271ORCIDFrom source
• Last synchronised4 November 2026 20:26https://www.medicalpark.com.tr/hekimler/dogan-uncumedicalpark.com.tr

1. Efficacy and safety of second-line treatments in ALK mutation-positive advanced non-small cell lung cancer after second- or third-generation ALK inhibitors: Turkish Oncology Group real-life study (TOG study)

   Clinical & Translational Oncology, 2026

   DOI 10.1007/s12094-026-04494-3 PMID 42400766 Source: OpenAlex

2. Effects of Immersive Virtual Reality and Relaxation Video on Symptom Severity, Distress, and Quality of Life in Lung Cancer Patients During Initial Chemotherapy Cycles: A Three-Arm Randomised Controlled Trial

   Healthcare, 2026

   DOI 10.3390/healthcare14203394 PMID 42940439 Open-access full textSource: ORCID

3. Clinicopathological Features of Intrahepatic Cholangiocarcinoma with Assessment of IDH1 Mutation: A Two-Center Retrospective Study

   Journal of Clinical Medicine, 2026

   DOI 10.3390/jcm15135290 PMID 42452749 Open-access full textSource: ORCID

4. A Machine Learning Framework for Prognostic Modeling in Stage III Colon Cancer

   Journal of Clinical Medicine, 2026

   DOI 10.3390/jcm15083091 PMID 42074893 Open-access full textSource: ORCID

5. Real-World Treatment Patterns and Survival in Uveal Melanoma: A Multicenter Cohort Study by the Turkish Oncology Group (TOG)

   Cancers, 2026

   DOI 10.3390/cancers18030394 PMID 41681877 1 citation (Europe PMC) Open-access full textSource: ORCID

6. Neoadjuvant chemotherapy with surgery versus concurrent chemoradiation in N2 non-small cell lung cancer: a retrospective comparative analysis of treatment outcomes

   Turkish Journal of Clinics and Laboratory, 2026

   DOI 10.18663/tjcl.1837114 Open-access full textSource: OpenAlex

7. Machine learning–based prediction of recurrence after curative resection in non–small cell lung cancer

   Scientific Reports, 2026

   DOI 10.1038/s41598-026-47862-3 PMID 41957214 Open-access full textSource: OpenAlex

8. Prediction of postoperative recurrence in non–small cell lung cancer using machine learning approaches.

   Journal of Clinical Oncology, 2026

   DOI 10.1200/jco.2026.44.16_suppl.e20020 Source: OpenAlex

9. Histological Grade, Tumor Size, and Surgical Margins as Key Predictors in Soft Tissue Sarcoma Outcomes: A Retrospective Cohort Analysis

   Indian Journal of Surgical Oncology, 2026

   DOI 10.1007/s13193-026-02607-6 Source: ORCID

10. Long-term cardiotoxicity outcomes of trastuzumab and cardiac safety of novel HER2-targeted therapies

    Expert Opinion on Drug Safety, 2026

    DOI 10.1080/14740338.2026.2667402 PMID 42080343 1 citation (OpenAlex) Source: OpenAlex